Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling

被引:87
作者
Ho, JMY
Beattie, BK
Squire, JA
Frank, DA
Barber, DL
机构
[1] Ontario Canc Inst, Div Cellular & Mol Biol, Toronto, ON M5G 2M9, Canada
[2] Toronto Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[4] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V93.12.4354.412k30_4354_4364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To study constitutive Janus kinase signaling, chimeric proteins were generated between the pointed domain of the ets transcription factor TEL and the cytosolic tyrosine kinase Jak2. The effects of these proteins on interleukin-3 (IL-3)-dependent proliferation of the hematopoietic cell line, Ba/F3, were studied, Fusion of TEL to the functional kinase (JH1) domain of Jak2 resulted in conversion of Ba/F3 cells to factor-independence. Importantly, fusion of TEL to the Jak2 pseudokinase (JH2) domain or a kinase-inactive Jak2 JH1 domain had no effect on IL-3-dependent proliferation of Ba/F3 cells. Active TEL-Jak2 constructs (consisting of either Jak2 JH1 or Jak2 JH2+JH1 domain fusions) were constitutively tyrosine-phosphorylated but did not affect phosphorylation of endogeneous Jak1, Jak2, or Jak3. TEL-Jak2 activation resulted in the constitutive tyrosine phosphorylation of Stat1, Stat3, and Stat5 as determined by detection of phosphorylation using activation-specific antibodies and by binding of each protein to a preferential GAS sequence in electrophoretic mobility shift assays. Elucidation of signaling events downstream of TEL Jak2 activation may provide insight into the mechanism of leukemogenesis mediated by this oncogenic fusion protein. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4354 / 4364
页数:11
相关论文
共 64 条
[51]  
Shuai K, 1996, ONCOGENE, V13, P247
[52]   STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION [J].
SILVENNOINEN, O ;
WITTHUHN, BA ;
QUELLE, FW ;
CLEVELAND, JL ;
YI, TL ;
IHLE, JN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8429-8433
[53]   CHOICE OF STATS AND OTHER SUBSTRATES SPECIFIED BY MODULAR TYROSINE-BASED MOTIFS IN CYTOKINE RECEPTORS [J].
STAHL, N ;
FARRUGGELLA, TJ ;
BOULTON, TG ;
ZHONG, Z ;
DARNELL, JE ;
YANCOPOULOS, GD .
SCIENCE, 1995, 267 (5202) :1349-1353
[54]   Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality [J].
Takeda, K ;
Noguchi, K ;
Shi, W ;
Tanaka, T ;
Matsumoto, M ;
Yoshida, N ;
Kishimoto, T ;
Akira, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3801-3804
[55]   Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses [J].
Teglund, S ;
McKay, C ;
Schuetz, E ;
van Deursen, JM ;
Stravopodis, D ;
Wang, DM ;
Brown, M ;
Bodner, S ;
Grosveld, G ;
Ihle, JN .
CELL, 1998, 93 (05) :841-850
[56]   Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells [J].
Thierfelder, WE ;
vanDeursen, JM ;
Yamamoto, K ;
Tripp, RA ;
Sarawar, SR ;
Carson, RT ;
Sangster, MY ;
Vignali, DAA ;
Doherty, PC ;
Grosveld, GC ;
Ihle, JN .
NATURE, 1996, 382 (6587) :171-174
[57]   DEFECTS IN B-LYMPHOCYTE MATURATION AND T-LYMPHOCYTE ACTIVATION IN MICE LACKING JAK3 [J].
THOMIS, DC ;
GURNIAK, CB ;
TIVOL, E ;
SHARPE, AH ;
BERG, LJ .
SCIENCE, 1995, 270 (5237) :794-797
[58]  
Tse K. F., 1997, Blood, V90, p311A
[59]  
vanderPlas DC, 1996, LEUKEMIA, V10, P1317
[60]   INTERLEUKIN-2 AND ERYTHROPOIETIN ACTIVATE STAT5/MGF VIA DISTINCT PATHWAYS [J].
WAKAO, H ;
HARADA, N ;
KITAMURA, T ;
MUI, ALF ;
MIYAJIMA, A .
EMBO JOURNAL, 1995, 14 (11) :2527-2535